Skip to main content
NVDA-1.38%AAPL+0.39%GOOGL-2.28%MSFT-0.70%AMZN-0.68%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.31%TSLA-2.02%SKHY+7.05%MU-2.75%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.71%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.36%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.41%AUDJPY-1.70%CHFJPY-1.62%NZDCAD-1.32%EURJPY-1.26%NZDUSD-1.26%GBPJPY-1.25%EURNZD+1.20%USDJPY-1.18%GBPNZD+1.17%CADJPY-1.10%USDZAR+0.84%NZDCHF-0.82%USDNOK+0.79%AUDNZD+0.74%USDSEK+0.70%AUDCAD-0.62%USDTHB+0.61%EURZAR+0.60%EURNOK+0.54%GBPZAR+0.54%AUDUSD-0.51%CADCHF+0.50%USDPLN+0.49%AUDSGD-0.48%USDMXN+0.48%AUDDKK-0.47%EURSEK+0.46%USDCHF+0.46%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%CHFNOK+0.39%EURCHF+0.36%GBPCHF+0.36%GBPHKD+0.32%SGDJPY+0.32%CHFSEK+0.31%NZDSGD-0.29%GBPMXN-0.28%EURHKD-0.26%USDDKK+0.25%USDSGD+0.24%EURPLN+0.24%NOKJPY-0.23%EURCNH-0.17%GBPCAD-0.16%USDILS+0.16%CHFSGD-0.16%EURCAD-0.15%USDTRY+0.11%EURUSD-0.08%GBPSGD-0.07%GBPUSD-0.07%PLNJPY+0.07%AUDCHF-0.07%NZDMXN-0.07%AUDNOK+0.06%USDCAD-0.06%USDCNH+0.06%USDCOP-0.04%EURCZK-0.02%EURGBP+0.02%EURSGD-0.01%USDHKD0.00%EURDKK0.00%GAGUSD-4.64%XAGUSD-4.64%XPTUSD-4.57%HG1-4.04%USOIL+3.43%UKOIL+3.26%COFFEE-2.23%XAUUSD-1.35%GAUUSD-1.34%SUGAR+0.65%XNGUSD-0.57%COTTON+0.32%BTCUSD-1.62%ETHUSD-1.43%USDTUSD-0.03%XRPUSD-2.04%SOLUSD-1.76%TRXUSDT+0.12%ZECUSDT-2.70%DOGEUSD-1.89%XMRUSDT-1.95%LINKUSD-1.00%XLMUSD-1.69%BCHUSDT-4.03%LTCUSD-2.05%UNIUSD-3.20%TONUSD+24.88%HBARUSDT-2.15%SUIUSD-2.13%TAOUSDT-3.31%AAVEUSD-2.63%DOTUSDT-2.36%ICPUSDT-1.44%ONDOUSDT-2.70%WLDUSDT-1.71%ATOMUSDT-2.97%ARBUSDT-0.78%JUPUSDT-3.39%INJUSDT-3.40%STXUSDT-3.80%FETUSDT-3.12%TIAUSDT-1.13%PYTHUSDT-1.61%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-4.03%OPUSDT-1.99%POLUSDT-6.46%IOTAUSDT-4.02%AXSUSDT-2.57%FARTCOINUSDT-4.23%EOSUSDT-0.31%DYDXUSDT-0.53%ORDIUSDT-0.40%GALAUSDT-4.21%NOTUSDT-0.68%RONINUSDT-1.67%NVDA-1.38%AAPL+0.39%GOOGL-2.28%MSFT-0.70%AMZN-0.68%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.31%TSLA-2.02%SKHY+7.05%MU-2.75%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.71%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.36%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.41%AUDJPY-1.70%CHFJPY-1.62%NZDCAD-1.32%EURJPY-1.26%NZDUSD-1.26%GBPJPY-1.25%EURNZD+1.20%USDJPY-1.18%GBPNZD+1.17%CADJPY-1.10%USDZAR+0.84%NZDCHF-0.82%USDNOK+0.79%AUDNZD+0.74%USDSEK+0.70%AUDCAD-0.62%USDTHB+0.61%EURZAR+0.60%EURNOK+0.54%GBPZAR+0.54%AUDUSD-0.51%CADCHF+0.50%USDPLN+0.49%AUDSGD-0.48%USDMXN+0.48%AUDDKK-0.47%EURSEK+0.46%USDCHF+0.46%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%CHFNOK+0.39%EURCHF+0.36%GBPCHF+0.36%GBPHKD+0.32%SGDJPY+0.32%CHFSEK+0.31%NZDSGD-0.29%GBPMXN-0.28%EURHKD-0.26%USDDKK+0.25%USDSGD+0.24%EURPLN+0.24%NOKJPY-0.23%EURCNH-0.17%GBPCAD-0.16%USDILS+0.16%CHFSGD-0.16%EURCAD-0.15%USDTRY+0.11%EURUSD-0.08%GBPSGD-0.07%GBPUSD-0.07%PLNJPY+0.07%AUDCHF-0.07%NZDMXN-0.07%AUDNOK+0.06%USDCAD-0.06%USDCNH+0.06%USDCOP-0.04%EURCZK-0.02%EURGBP+0.02%EURSGD-0.01%USDHKD0.00%EURDKK0.00%GAGUSD-4.64%XAGUSD-4.64%XPTUSD-4.57%HG1-4.04%USOIL+3.43%UKOIL+3.26%COFFEE-2.23%XAUUSD-1.35%GAUUSD-1.34%SUGAR+0.65%XNGUSD-0.57%COTTON+0.32%BTCUSD-1.62%ETHUSD-1.43%USDTUSD-0.03%XRPUSD-2.04%SOLUSD-1.76%TRXUSDT+0.12%ZECUSDT-2.70%DOGEUSD-1.89%XMRUSDT-1.95%LINKUSD-1.00%XLMUSD-1.69%BCHUSDT-4.03%LTCUSD-2.05%UNIUSD-3.20%TONUSD+24.88%HBARUSDT-2.15%SUIUSD-2.13%TAOUSDT-3.31%AAVEUSD-2.63%DOTUSDT-2.36%ICPUSDT-1.44%ONDOUSDT-2.70%WLDUSDT-1.71%ATOMUSDT-2.97%ARBUSDT-0.78%JUPUSDT-3.39%INJUSDT-3.40%STXUSDT-3.80%FETUSDT-3.12%TIAUSDT-1.13%PYTHUSDT-1.61%SEIUSDT-3.91%IMXUSDT-3.06%WIFUSDT-3.91%GRTUSDT-4.03%OPUSDT-1.99%POLUSDT-6.46%IOTAUSDT-4.02%AXSUSDT-2.57%FARTCOINUSDT-4.23%EOSUSDT-0.31%DYDXUSDT-0.53%ORDIUSDT-0.40%GALAUSDT-4.21%NOTUSDT-0.68%RONINUSDT-1.67%
AN

AnaptysBio, Inc. (ANAB)

NASDAQ • Healthcare

$55.7
-$0.89 (-1.6%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$55.59
Day Range$55.25 - $57.89
Avg. Volume (3M)441.3K
Market Cap$1.6B
52 Week Range
$11.41$72.36
Next EarningsIn 61 daysNov 10, 2026

Metrics Over Time

Where the Money Goes

Q1 2026
Revenueeverything earned$25.5M100%
Gross Profitminus cost of goods$24.9M98%

Fundamentals & Financials

Revenue (TTM)
$232.3M
Net Income (TTM)
-$26.7M
EPS (TTM)
-$0.87
ROA (TTM)
-8.13%
Current Ratio
7.58

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+77.5%Q1 2026$1.58
-475.0%Q2 2026-$1.84
+25.0%Q3 2026-$0.31
Next

Nov 10

in 61 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

AnaptysBio, Inc. (ANAB) reports on November 10, 2026. The market is looking for consensus EPS of -$0.06 on revenue of $7.0 million. For trailing context, revenue declined -8.0% year over year last quarter. ANAB has beaten EPS in 7 of 8 most recent quarters.

View full earnings history

About AnaptysBio, Inc.

AnaptysBio, Inc. is a biotechnology company listed on NASDAQ as ANAB that develops antibody-based medicines for autoimmune, inflammatory, and other immune-mediated diseases in the United States. FY2025 revenue was $234.6 million. Its work centers on immunology therapeutics and partnered antibody programs advanced through preclinical and clinical milestones.

Name
AnaptysBio, Inc.
CEO
Daniel Faga
Website
www.anaptysbio.com
Industry
Healthcare
Year Founded
2005
Employees
104

Today's Snapshot

AI-generated

ANAB closed 1.6% lower at 55.70.

Trading Volume

Below 10d avg (539.1K)

295.6K

vs S&P 500 Today

Underperforming Market

-1.11%

Updated: September 10, 2026 at 12:11 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
ANAB displays short-term pressure with price below its 10- and 20-period averages and negative momentum and MACD readings, which contribute to the sell bias. Meanwhile, longer-term averages remain below price, so the broader trend has not fully reversed. ADX indicates a weak trend and ATR points to elevated but not extreme volatility, while volume (OBV) reflects distribution. Oscillators sit near neutral, keeping signals mixed despite near-term downside bias. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$45.40 - $56.94
    Sell
  • RSI (14)45.85
    Neutral
  • Stochastic %K (14, 3, 3)30.96
    Neutral
  • MACD Level (12, 26)-0.19
    Sell

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$107.04-1.9%
NRIXNurix Therapeutics, Inc.
$26.26+0.5%
URGNUroGen Pharma Ltd.
$45+2.7%
KODKodiak Sciences Inc.
$33.78-3.7%
XNCRXencor, Inc.
$24.94-1.5%
TSHATaysha Gene Therapies, Inc.
$5.34-2.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.